Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment.

Current vascular pharmacology - 1 Jan 2015

Daskalopoulos Georgios, Karkanaki Artemis, Piouka Athanasia, Prapas Nikolaos, Panidis Dimitrios, Gkeleris Paraschos, Athyros Vasilios G

Abstract excerpt

AIM: To assess the potential differences in the metabolic and cardiovascular disease (CVD) risk between the distinct phenotypes of the Polycystic Ovary Syndrome (PCOS) according to the Rotterdam definition regardless of body mass index (BMI). PATIENTS-METHODS: The study included 300 women; 240 women with PCOS, according to the Rotterdam criteria and 60 controls without PCOS. All women were further subdivided,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis
Share to Body Mass Index

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to C-Reactive Protein

Share to Cardiovascular Diseases

Share to Metabolic Syndrome

Share to Non-alcoholic Fatty Liver Disease

Share to Overweight

Share to Polycystic Ovary Syndrome

Source

Identifiers

PMID: 25600030
DOI: 10.2174/1567201812666150120163025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment.PMID 25600030Read ↗

Metabolic syndrome and its components in different phenotypes of polycystic ovary syndrome.Semantic proximity Read ↗

Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.Semantic proximity Read ↗

Not all women diagnosed with PCOS share the same cardiovascular risk profiles.Semantic proximity Read ↗

Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.Semantic proximity Read ↗

Visceral Adiposity Index in Relation to Rotterdam Phenotypes of Polycystic Ovary SyndromeSemantic proximity Read ↗

Metabolic risk in PCOS: phenotype and adiposity impact.Semantic proximity Read ↗

Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.Semantic proximity Read ↗

Cardiovascular Risk in the Different Phenotypes of Polycystic Ovary Syndrome.Semantic proximity Read ↗

The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.Semantic proximity Read ↗

Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.Semantic proximity Read ↗

Body Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypes.Semantic proximity Read ↗

Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.